C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins. Its lead product candidate is Cemsidomide, an orally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback